Cargando…
Could a revision of the current guidelines for cancer drug use improve the quality of cancer treatment?
Clinical practice guidelines are indispensable for such a variable disease as malignant solid tumors, with the complex possibilities of drug treatment. The current guidelines may be criticized on several points, however. First, there is a lack of information on the outcome of treatment, such as the...
Autores principales: | Lippert, Theodor H, Ruoff, Hans-Jörg, Volm, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913602/ https://www.ncbi.nlm.nih.gov/pubmed/24511236 http://dx.doi.org/10.2147/TCRM.S51404 |
Ejemplares similares
-
Current Status of Methods to Assess Cancer Drug Resistance
por: Lippert, Theodor H., et al.
Publicado: (2011) -
Prediction of Cancer Drug Resistance and Implications for Personalized Medicine
por: Volm, Manfred, et al.
Publicado: (2015) -
Perspective: Improving Nutritional Guidelines for Sustainable Health Policies: Current Status and Perspectives
por: Magni, Paolo, et al.
Publicado: (2017) -
How Industry Uses the ICMJE Guidelines to Manipulate Authorship—And How They Should Be Revised
por: Matheson, Alastair
Publicado: (2011) -
Abandon of intramuscular administration of rabies immunoglobulin for post-exposure prophylaxis in the revised guidelines in the Netherlands in 2018: cost and volume savings
por: Schreuder, Imke, et al.
Publicado: (2020)